Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Complications of Diagnostic and Therapeutic Ercp: A Prospective Multicenter Study
2001667 citationsE. Masci, U Comin et al.profile →
Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease
2000502 citationsMario Guslandi, M. Sorghi et al.profile →
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014
2014403 citationsAlberto Mariani, Pier Alberto Testoni et al.Endoscopyprofile →
Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
2016358 citationsPier Alberto Testoni, Alberto Mariani et al.Endoscopyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Pier Alberto Testoni
Since
Specialization
Citations
This map shows the geographic impact of Pier Alberto Testoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pier Alberto Testoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pier Alberto Testoni more than expected).
Fields of papers citing papers by Pier Alberto Testoni
This network shows the impact of papers produced by Pier Alberto Testoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pier Alberto Testoni. The network helps show where Pier Alberto Testoni may publish in the future.
Co-authorship network of co-authors of Pier Alberto Testoni
This figure shows the co-authorship network connecting the top 25 collaborators of Pier Alberto Testoni.
A scholar is included among the top collaborators of Pier Alberto Testoni based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Pier Alberto Testoni. Pier Alberto Testoni is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Testoni, Pier Alberto & Sabrina Gloria Giulia Testoni. (2020). ERCP-Guided Endoscopic Therapy for Recurrent Acute Pancreatitis in Normal Pancreas and Chronic Pancreatitis. JOP, journal of the pancreas. 21(5).
Nardi, Paola De, Maura Corsetti, Sandro Passaretti, Pier Alberto Testoni, & C. Staudacher. (2007). Evaluation of sensory and motor rectal response after hemorrhoidopexy with electronic barostat. Diseases of the Colon & Rectum. 50(5). 789–789.1 indexed citations
12.
Testoni, Pier Alberto, Marco Cicardi, Luigi Bergamaschini, et al.. (1993). Efficiacy of C1-inhibitor plasma concentrate, the main kallikrein inactivator, in preventing hyperamylasemia induced by endoscopic papillosphincterotomy. Endoscopy. 25(5). 344–345.1 indexed citations
13.
Tosi, T., et al.. (1992). Levosulpiride and racemic sulpiride in non ulcer dyspepsia results of a randomized clinical study. Current Therapeutic Research. 51(6). 787–791.2 indexed citations
14.
Masci, E., M. Sorghi, T. Tosi, Pier Alberto Testoni, & A. Tittobello. (1992). Levosulpiride and domperidone in the treatment of reflux esophagitis : results of a double-blind study versus placebo. Current Therapeutic Research. 51(6). 814–818.5 indexed citations
15.
Testoni, Pier Alberto, E. Masci, F. Bagnolo, et al.. (1990). Effect of long-term oral therapy with cisapride in reflux antral gastritis: results of a double-blind placebo-controlled trial. Current Therapeutic Research. 47(1). 156–165.4 indexed citations
16.
Testoni, Pier Alberto, E. Masci, F. Bagnolo, & A. Tittobello. (1988). Endoscopic papillo-sphincterotomy: Prevention of pancreatic reaction by somatostatin. 20(2). 70–73.25 indexed citations
17.
Testoni, Pier Alberto, E. Masci, Sandro Passaretti, et al.. (1986). Comparison of somatostatin and cimetidine in the treatment of acute bleeding esophageal varices. Current Therapeutic Research. 39(5). 758–766.18 indexed citations
18.
Guslandi, Mario, E. Masci, Pier Alberto Testoni, & Elena Ballarín. (1983). Comparison of cimetidine and ranitidine in long-term treatment of duodenal ulcer. Clinical Trials. 20(2). 67–70.6 indexed citations
19.
Guslandi, Mario, et al.. (1981). Clinical evaluation of octatropine methylbromide plus diazepam (Valpinax* * Valpinax, Crinos S.p.A., Villaguardia (Como), Italy) in the treatment of irritable bowel syndrome. Clinical Trials. 18(2). 138–144.2 indexed citations
20.
Guslandi, Mario, Pier Alberto Testoni, & E. Fesce. (1980). Behaviour of gastric mucin during pirenzepine treatment: A double-blind controlled study versus cimetidine. Current Therapeutic Research. 27(5). 714–718.10 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.